Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OHB Neonatology
Altrincham, England, United Kingdomorpha.net ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Oak Hill Bio is a clinical-stage biotechnology company focused on developing therapies for neonatology and rare diseases. Its lead candidate, OHB‑607, a recombinant human IGF‑1/IGFBP‑3 complex, is in a resumed Phase 2b trial for prevention of bronchopulmonary dysplasia in extremely premature infants. Early clinical data show potential to reduce severe BPD incidence with no significant safety signals observed[1][5][7]. The company also has late-stage programs targeting Angelman syndrome and other rare conditions[4][8].
- Therapeutic areas
- OphthalmologyPulmonologyNeurology
- Modalities
- Antisense oligonucleotideRecombinant proteinSmall molecule
- Industry
- Biotech
02
Partnerships
Chiesi Group – co-development and commercialization partnership for OHB–607[1][5]Roche – exclusive license agreement for global rights to rugonersen/Angelman syndrome program[4]
Beyond the preview
Go deeper on OHB Neonatology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OHB Neonatology.